Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 308

1.

The prognostic value of serum c-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.

Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, Lazarus HM, Litzow M, Loren A, Majhail NS, Maziarz RT, McCarthy P, Popat U, Saber W, Spellman S, Ringden O, Wickrema A, Pasquini MC, Cooke KR.

Haematologica. 2016 Aug 4. pii: haematol.2016.145847. [Epub ahead of print]

2.

Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

Hefazi M, Damlaj M, Alkhateeb H, Partain DK, Patel R, Razonable RR, Gastineau DA, Al-Kali A, Hashmi S, Hogan WJ, Litzow MR, Patnaik MM.

Transpl Infect Dis. 2016 Sep 19. doi: 10.1111/tid.12612. [Epub ahead of print]

PMID:
27642723
3.

Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.

Baljevic M, Dumitriu B, Lee JW, Paietta EM, Wiernik PH, Racevskis J, Chen C, Stein EM, Gallagher RE, Rowe JM, Appelbaum FR, Powell BL, Larson RA, Coutré SE, Lancet J, Litzow MR, Luger SM, Young NS, Tallman MS.

Acta Haematol. 2016 Sep 16;136(4):210-218. [Epub ahead of print]

PMID:
27632567
4.

Therapy-related myeloid neoplasms - what have we learned so far?

Zahid MF, Parnes A, Savani BN, Litzow MR, Hashmi SK.

World J Stem Cells. 2016 Aug 26;8(8):231-42. doi: 10.4252/wjsc.v8.i8.231. Review.

5.

Hypereosinophilic syndrome presenting with multiple organ infiltration and deep venous thrombosis: A case report and literature review.

Gao SJ, Wei W, Chen JT, Tan YH, Yu CB, Litzow MR, Liu QJ.

Medicine (Baltimore). 2016 Aug;95(35):e4658. doi: 10.1097/MD.0000000000004658.

6.

Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008.

Ganzel C, Manola J, Douer D, Rowe JM, Fernandez HF, Paietta EM, Litzow MR, Lee JW, Luger SM, Lazarus HM, Cripe LD, Tallman MS.

J Clin Oncol. 2016 Aug 29. pii: JCO675892. [Epub ahead of print]

PMID:
27573652
7.

Acute leukemia in pregnancy: a single institution experience with 23 patients.

Farhadfar N, Cerquozzi S, Hessenauer MR, Litzow MR, Hogan WJ, Letendre L, Patnaik MM, Tefferi A, Gangat N.

Leuk Lymphoma. 2016 Aug 26:1-9. [Epub ahead of print]

PMID:
27562538
8.

A Phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms and chronic myelomonocytic leukemia.

Pratz KW, Rudek MA, Gojo I, Litzow MR, McDevitt MA, Ji JJ, Karnitz L, Herman JG, Kinders R, Smith BD, Gore SD, Carraway H, Showel MM, Gladstone DE, Levis MJ, Tsai HL, Rosner GL, Chen A, Kaufmann SH, Karp J.

Clin Cancer Res. 2016 Aug 22. pii: clincanres.1274.2016. [Epub ahead of print]

PMID:
27551000
9.

New monoclonal antibodies for the treatment of acute lymphoblastic leukemia.

Farhadfar N, Litzow MR.

Leuk Res. 2016 Jul 26;49:13-21. doi: 10.1016/j.leukres.2016.07.009. [Epub ahead of print] Review.

PMID:
27521873
10.

Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII.

Kumar AJ, Gimotty PA, Gelfand J, Buck G, Rowe JM, Goldstone AH, Fielding A, Marks DI, Litzow M, Paietta E, Lazarus HM, Tallman MS, Luger SM, Loren AW.

Am J Hematol. 2016 Jul 28. doi: 10.1002/ajh.24497. [Epub ahead of print]

PMID:
27468137
11.

A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia.

Luskin MR, Gimotty PA, Smith C, Loren AW, Figueroa ME, Harrison J, Sun Z, Tallman MS, Paietta EM, Litzow MR, Melnick AM, Levine RL, Fernandez HF, Luger SM, Carroll M, Master SR, Wertheim GB.

JCI Insight. 2016 Jun 16;1(9). pii: e87323.

12.

Medical Students' Knowledge, Familiarity, and Attitudes towards Hematopoietic Stem Cell Donation: Stem Cell Donation Behaviors.

Narayanan P, Wolanskyj A, Ehlers SL, Litzow MR, Patnaik MS, Hogan WJ, Hashmi SK.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1710-6. doi: 10.1016/j.bbmt.2016.06.014. Epub 2016 Jun 22.

PMID:
27343721
13.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.

Deol A, Sengsayadeth S, Ahn KW, Wang HL, Aljurf M, Antin JH, Battiwalla M, Bornhauser M, Cahn JY, Camitta B, Chen YB, Cutler CS, Gale RP, Ganguly S, Hamadani M, Inamoto Y, Jagasia M, Kamble R, Koreth J, Lazarus HM, Liesveld J, Litzow MR, Marks DI, Nishihori T, Olsson RF, Reshef R, Rowe JM, Saad AA, Sabloff M, Schouten HC, Shea TC, Soiffer RJ, Uy GL, Waller EK, Wiernik PH, Wirk B, Woolfrey AE, Bunjes D, Devine S, de Lima M, Sandmaier BM, Weisdorf D, Khoury HJ, Saber W.

Cancer. 2016 Oct;122(19):3005-14. doi: 10.1002/cncr.30140. Epub 2016 Jun 17.

PMID:
27315441
14.

Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic Dosing.

Damlaj M, Alkhateeb HB, Hefazi M, Partain DK, Hashmi S, Gastineau DA, Al-Kali A, Wolf RC, Gangat N, Litzow MR, Hogan WJ, Patnaik MM.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1431-9. doi: 10.1016/j.bbmt.2016.04.026. Epub 2016 May 7.

PMID:
27164061
15.

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis.

Yang X, Pang J, Shen N, Yan F, Wu LC, Al-Kali A, Litzow MR, Peng Y, Lee RJ, Liu S.

Oncotarget. 2016 Apr 20. doi: 10.18632/oncotarget.8871. [Epub ahead of print]

16.

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

Ustun C, Gotlib J, Popat U, Artz A, Litzow M, Reiter A, Nakamura R, Kluin-Nelemans HC, Verstovsek S, Gajewski J, Perales MA, George T, Shore T, Sperr W, Saber W, Kota V, Yavuz AS, Pullarkat V, Rogosheske J, Hogan W, Van Besien K, Hagglund H, Damaj G, Arock M, Horny HP, Metcalfe DD, Deeg HJ, Devine S, Weisdorf D, Akin C, Valent P.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1348-56. doi: 10.1016/j.bbmt.2016.04.018. Epub 2016 Apr 27. No abstract available.

PMID:
27131865
17.

Is It Time for a New Gold Standard? FISH vs Cytogenetics in AML Diagnosis.

Hammer RD, Doll D, Layfield L, He R, Reichard KK, Hanson CA, Kurtin PJ, Howard MT, Litzow MR, Van Dyke DL, Ketterling RP, Wiktor AE.

Am J Clin Pathol. 2016 Mar;145(3):430-2. doi: 10.1093/ajcp/aqw008. No abstract available.

PMID:
27124927
18.

Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis.

Zahid MF, Murad MH, Litzow MR, Hogan WJ, Patnaik MS, Khorana A, Spyropoulos AC, Hashmi SK.

Ann Hematol. 2016 Sep;95(9):1457-64. doi: 10.1007/s00277-016-2673-3. Epub 2016 Apr 22. Review.

PMID:
27103008
19.

Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia.

Dias A, Kenderian SJ, Westin GF, Litzow MR.

Curr Hematol Malig Rep. 2016 Aug;11(4):253-64. doi: 10.1007/s11899-016-0326-1. Review.

PMID:
27101015
20.

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment.

Gangat N, Patnaik MM, Begna K, Al-Kali A, Litzow MR, Ketterling RP, Hanson CA, Pardanani AD, Tefferi A.

Blood Cancer J. 2016 Apr 8;6:e414. doi: 10.1038/bcj.2016.23. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk